NERV
NASDAQ
US
Minerva Neurosciences, Inc - Common Stock
$5.28
▼ $-0.32
(-5.71%)
Vol 179K
3
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$28.1M
ROE
-169.6%
D/E
0.00
Beta
-0.15
52W
$1–$12
Wall Street Consensus
7 analysts · Apr 20260
Strong Buy
0
Buy
4
Hold
1
Sell
2
Strong Sell
0.0%
Buy Rating
Price Chart
Similar Stocks
VYGR
Voyager Therapeutics Inc
$218.5M
RNA
Atrium Therapeutics Inc
$10.9B
ELDN
Eledon Pharmaceuticals Inc
$113.4M
CAMP
CAMP4 Therapeutics Corp
$318.0M
ARCT
Arcturus Therapeutics Holdings Inc
$174.2M
FENC
Fennec Pharmaceuticals Inc
$262.9M
KRRO
Korro Bio Inc
$75.4M
NVCT
Nuvectis Pharma Inc
$193.4M
ANIK
Anika Therapeutics Inc
$138.6M
Earnings
Beat rate: 75.0%
Next Report
May 11, 2026
EPS Estimate: $-0.13
| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Mar 2026 | $-0.13 | — | — |
| Dec 2025 | $-0.31 | $-0.64 | $-0.33 |
| Jun 2025 | $-0.92 | $-0.43 | +$0.49 |
| Mar 2025 | $-1.09 | $-0.50 | +$0.59 |
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | — | -169.6% | -169.6% | -169.6% | -169.6% | -169.6% |
| P/E (TTM) | 1.07 | 2.56 | 1.31 | 2.62 | — | — |
| Net Margin | — | — | — | — | — | — |
| Gross Margin | — | — | — | — | — | — |
| D/E Ratio | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Current Ratio | 6.15 | 9.21 | 6.15 | 6.15 | 4.87 | 4.87 |
Key Ratios
ROA (TTM)
-43.7%
P/B
4.3
EPS (TTM)
$-1.85
CF/Share
$-3.53
52W High
$12.46
52W Low
$1.15
$1.15
52-Week Range
$12.46
How does NERV compare to Biotechnology peers?
Peer group: Micro-cap Biotechnology (All) · 528 companies
NERV valuation vs Biotechnology peers
P/E ratio
—
▼
0%
below
peers
(18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
—
▼
0%
below
peers
(12.9)
vs Peers
vs Industry
Overvalued
P/B ratio
4.3
▲
74%
above
peers
(2.5)
vs Peers
vs Industry
Overvalued
Div yield
—
▼
0%
below
peers
(0.0%)
vs Peers
vs Industry
Low yield
NERV profitability vs Biotechnology peers
ROE
-169.6%
▼
152%
below
peers
(-67.3%)
vs Peers
vs Industry
Weak
Net margin
—
▼
0%
below
peers
(-286.8%)
vs Peers
vs Industry
Top tier
Gross margin
—
▼
0%
below
peers
(78.6%)
vs Peers
vs Industry
In line
ROA
-43.7%
▲
6%
above
peers
(-46.7%)
vs Peers
vs Industry
In line
NERV financial health vs Biotechnology peers
D/E ratio
0.0
▼
0%
below
peers
(0.0)
vs Peers
vs Industry
Low debt
Current ratio
4.9
▲
10%
above
peers
(4.4)
vs Peers
vs Industry
In line
Beta
-0.2
▼
116%
below
peers
(1.0)
vs Peers
vs Industry
More volatile
NERV fundamentals radar
NERV
Peer median
Industry
NERV profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
NERV vs peers: key metrics
Latest News
Nervous About the Market? 3 Vanguard ETFs That Were Made for Times …
Nasdaq · Mar 30
Nervous About the Oil Crisis? This Market-Crushing Stock is an Absolute No-Brainer …
Nasdaq · Mar 24
A Quarter Of Americans Admit They Want To Invest But Don't Know …
Yahoo Finance · Mar 19
1 Reason Nuscale Power and Oklo Investors Should Be Extremely Nervous in …
www.fool.com · Feb 27